Roivant Sciences Ltd. (NASDAQ:ROIV) is a clinical-stage biopharmaceutical company that discovers, develops, and ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...

OPKO Health has improved its financial position by selling most of BioReference, reducing cash burn, and strengthening its balance sheet. Ngenla's profit share with Pfizer has underperformed ...

Ipsen gains exclusive global rights, outside of Greater China, for development, manufacturing and commercialization of SIM0613, a ...

In July 2025, Novartis Pharmaceuticals conducted a study is to assess the effect of Iptacopan to prevent conversion of early ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

Absci Corporation has announced significant advancements in its drug development pipeline during its 2024 R&D Day. The company highlighted the selection of ABS-201, a novel anti-PRLR antibody ...

AI’s true promise is turning clinical development from a bottleneck into a throughput engine for human health. Drug discovery ...

America, since the conclusion of World War II, has dominated the R&D pipeline. Past research from our team at the Center for ...